Not available
Quote | Trinity Biotech plc (NASDAQ:TRIB)
Last: | $1.8054 |
---|---|
Change Percent: | 2.13% |
Open: | $1.84 |
Close: | $1.8054 |
High: | $1.84 |
Low: | $1.7994 |
Volume: | 5,746 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | Trinity Biotech plc (NASDAQ:TRIB)
2024-04-04 15:03:06 ET Trinity Biotech plc (TRIB) Q4 2023 Earnings Conference Call April 04, 2024 08:00 a.m. ET Company Participants John Gillard - Chief Executive Officer Des Fitzgerald - Chief Financial Officer Eric Ribner - Investor Relations Conference ...
DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter ended December 31, 2023 and fisca...
Message Board Posts | Trinity Biotech plc (NASDAQ:TRIB)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $TRIB News Article - Trinity Biotech Welcomes TrinScreen HIV's Inclusion In The New Ken | whytestocks | investorshangout | 03/22/2023 7:45:46 PM |
whytestocks: $TRIB News Article - Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Fin | whytestocks | investorshangout | 12/09/2022 1:10:46 PM |
Close at .98 would be a nice double | StockLogistics | investorshub | 09/06/2022 7:01:09 AM |
whytestocks: $TRIB News Article - Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial | whytestocks | investorshangout | 04/11/2022 2:10:50 PM |
Today. | stocks2watch | investorshub | 04/11/2022 1:09:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Trinity Biotech plc Company Name:
TRIB Stock Symbol:
NASDAQ Market:
DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter ended December 31, 2023 and fisca...
DUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB) (the "Company"), a leading developer and manufacturer of d...
DUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal...